SHSE:688426 (China)
Â
Class A
Â¥
15.33
+0.38 (+2.54%)
Jul 27
Business Description
Jiangsu Cowin Biotech Co Ltd
ISIN : CNE100005NM2
Share Class Description:
SHSE:688426: Class ATotal Employee Number:
769Compare
Compare
Traded in other countries / regions
688426.China Index Membership
SSE Composite Index IPO Date
2022-10-25Description
Jiangsu Cowin Biotech Co Ltd is a national high-tech enterprise with independent intellectual property rights based in the field of life sciences. It provides innovative biological products and services to in vitro diagnostic users. The product line mainly includes molecular diagnostic raw materials enzymes, nucleic acid collection and protection agents, nucleic acid extraction kits, molecular diagnostic detection reagents and others.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 70.16 | |||||
Equity-to-Asset | 0.91 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.11 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 8.37 | |||||
Beneish M-Score | -2.21 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -32.1 | |||||
3-Year Book Growth Rate | -8.9 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 19.75 | |||||
9-Day RSI | 28.2 | |||||
14-Day RSI | 33.03 | |||||
3-1 Month Momentum % | -4.62 | |||||
6-1 Month Momentum % | -33.13 | |||||
12-1 Month Momentum % | -19.26 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 13.76 | |||||
Quick Ratio | 13.07 | |||||
Cash Ratio | 10.71 | |||||
Days Inventory | 169.03 | |||||
Days Sales Outstanding | 108.92 | |||||
Days Payable | 68.29 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | 0.79 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 44.82 | |||||
Operating Margin % | -51.65 | |||||
Net Margin % | -47.74 | |||||
EBITDA Margin % | -46.38 | |||||
FCF Margin % | -47.49 | |||||
OCF Margin % | -35.64 | |||||
ROE % | -7.22 | |||||
ROA % | -6.5 | |||||
ROIC % | -12.6 | |||||
3-Year ROIIC % | -66.9 | |||||
ROC (Joel Greenblatt) % | -15.02 | |||||
ROCE % | -6.63 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 11.53 | |||||
PS Ratio | 8.05 | |||||
PB Ratio | 1.29 | |||||
Price-to-Tangible-Book | 1.34 | |||||
EV-to-EBIT | -10.47 | |||||
EV-to-EBITDA | -10.47 | |||||
EV-to-Revenue | 4.86 | |||||
EV-to-FCF | -10.22 | |||||
Price-to-GF-Value | 0.52 | |||||
| Price-to-Net-Current-Asset-Value | 2.17 | |||||
| Price-to-Net-Cash | 2.93 | |||||
Earnings Yield (Greenblatt) % | -9.55 | |||||
FCF Yield % | -5.77 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Jiangsu Cowin Biotech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 209.512 | ||
| EPS (TTM) (Â¥) | -0.907 | ||
| Beta | 1.8143 | ||
| 3-Year Sharpe Ratio | -0.07 | ||
| 3-Year Sortino Ratio | -0.1 | ||
| Volatility % | 38.55 | ||
| 14-Day RSI | 33.03 | ||
| 14-Day ATR (Â¥) | 1.014581 | ||
| 20-Day SMA (Â¥) | 16.973 | ||
| 12-1 Month Momentum % | -19.26 | ||
| 52-Week Range (Â¥) | 14.42 - 33.67 | ||
| Shares Outstanding (Mil) | 112.49 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Jiangsu Cowin Biotech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Jiangsu Cowin Biotech Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| 1.2:1 Stock Split | 2023-06-12 | 29.35 (-3.85%) |
Show
Entries
Jiangsu Cowin Biotech Co Ltd Frequently Asked Questions
What is Jiangsu Cowin Biotech Co Ltd(SHSE:688426)'s stock price today?
The current price of SHSE:688426 is ¥15.33. The 52 week high of SHSE:688426 is ¥33.67 and 52 week low is ¥14.42.
When is next earnings date of Jiangsu Cowin Biotech Co Ltd(SHSE:688426)?
The next earnings date of Jiangsu Cowin Biotech Co Ltd(SHSE:688426) is .
Does Jiangsu Cowin Biotech Co Ltd(SHSE:688426) pay dividends? If so, how much?
Jiangsu Cowin Biotech Co Ltd(SHSE:688426) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Jiangsu Cowin Biotech Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers